REG - Nanosynth Group PLC - Directorate Change

NanosynthAnnouncement

22/12/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211222:nRSV4125Wa&default-theme=true

RNS Number : 4125W  Nanosynth Group PLC  22 December 2021

 

22 December 2021

 

nanosynth group plc

("nanosynth", the "Company" or the "Group")

Board change

nanosynth group plc, the AIM quoted company is pleased to announce that Dr
Gareth Cave, currently a Non-executive Director of the Company, has today been
appointed as an Executive Director and as the Group's Chief Scientific
Officer. Dr Cave's intended change of role, which at that time was subject to
contract, was announced on 1 September 2021.

Dr Cave is a university chemistry lecturer and has spent his academic career
researching many applications of nanotechnology, from drug delivery systems to
plant food.  Beyond academia, as an active consultant, he shares his
knowledge and know-how across a plethora of industries including
pharmaceutical, healthcare, materials, agricultural, food and drink
industries.  In 2015 he formed Pharm 2 Farm Ltd, a wholly owned subsidiary of
nanosynth group plc, as a university spinout, to help realise the full
commercial potential of this nanotechnology research.

He has B.Sc., M.Sc. and Ph.D. chemistry degrees from the University of
Warwick, is an active member of the Royal Society of Chemistry and has worked
as an academic in UK, USA and Australian universities over the course of his
career.

Mark Duffin, CEO commented: "I am delighted to formalise the agreement for
Gareth to become part of the Executive team as Chief Scientific Officer. His
skills and experience are ideally suited to guiding us through this exciting
and innovative time in the Group's development."

 

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulations
(EU) No. 596/2014 ('MAR') which has been incorporated into UK law by
the European Union (Withdrawal) Act 2018.  Upon the publication of this
announcement via Regulatory Information Service ('RIS'), this inside is now
considered to be in the public domain.

 

 

 

 

ENQUIRIES :

 nanosynth group plc                                              via IFC Advisory

 Mark Duffin (Chief Executive Officer)

 SP Angel Corporate Finance LLP                                   +44 20 3470 0470

 Nominated Adviser and Broker

 Stuart Gledhill

 Caroline Rowe

 IFC Advisory Ltd                                                 +44 20 3934 6630

 Graham Herring

 Zach Cohen

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOADZMZZRMGGMZM